https://www.selleckchem.com/pr....oducts/gsk2879552-2h
94 (1.01-24.48); p value = 0.048]. Furthermore, NLR and ECOG are independent prognostic factors for progression-free survival (PFS) and overall survival (OS). Specifically, PFS was 25.79 months for the good prognosis group and 12.09 for the poor prognosis group [HR 2.98 (CI 95% = 1.74-5.1, p less then 0.001]; and OS was 42.94 months and 18.86 months, respectively [HR 2.81 (CI 95% = 1.62-4.9, p less then 0.001]. Conclusion Dynamics of NLR have a prognostic value in stage III NSCLC treated with definitive CRT. Pre- and post-CR
Like
Comment
Share
